INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)

Clinical trial NCT07417618 · COMPLETED

Trial details

NCT number: NCT07417618
Sponsor: Brigham and Women's Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Type 2 Diabetes Overweight ASCVD

Start date: 2026-01-27
Primary completion: 2026-06-19
Enrollment: 60000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.